Check-Cap (CHEK) Competitors $0.64 +0.00 (+0.75%) Closing price 03:58 PM EasternExtended Trading$0.65 +0.00 (+0.43%) As of 05:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock CHEK vs. DRCT, SLGL, BTCY, NXL, TNON, MHUA, XAIR, LYRA, DHAI, and OSRHShould you be buying Check-Cap stock or one of its competitors? The main competitors of Check-Cap include Direct Digital (DRCT), Sol-Gel Technologies (SLGL), Biotricity (BTCY), Nexalin Technology (NXL), Tenon Medical (TNON), Meihua International Medical Technologies (MHUA), Beyond Air (XAIR), Lyra Therapeutics (LYRA), DIH Holding US (DHAI), and OSR (OSRH). Check-Cap vs. Its Competitors Direct Digital Sol-Gel Technologies Biotricity Nexalin Technology Tenon Medical Meihua International Medical Technologies Beyond Air Lyra Therapeutics DIH Holding US OSR Direct Digital (NASDAQ:DRCT) and Check-Cap (NASDAQ:CHEK) are related small-cap companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, media sentiment, risk, valuation, dividends and earnings. Does the media refer more to DRCT or CHEK? In the previous week, Direct Digital had 2 more articles in the media than Check-Cap. MarketBeat recorded 3 mentions for Direct Digital and 1 mentions for Check-Cap. Check-Cap's average media sentiment score of 1.11 beat Direct Digital's score of -1.00 indicating that Check-Cap is being referred to more favorably in the news media. Company Overall Sentiment Direct Digital Negative Check-Cap Positive Which has preferable valuation & earnings, DRCT or CHEK? Direct Digital has higher revenue and earnings than Check-Cap. Direct Digital is trading at a lower price-to-earnings ratio than Check-Cap, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDirect Digital$62.29M0.16-$6.24M-$1.83-0.24Check-CapN/AN/A-$17.57M-$3.00-0.21 Which has more volatility & risk, DRCT or CHEK? Direct Digital has a beta of 6.04, suggesting that its stock price is 504% more volatile than the S&P 500. Comparatively, Check-Cap has a beta of 0.19, suggesting that its stock price is 81% less volatile than the S&P 500. Do insiders & institutionals hold more shares of DRCT or CHEK? 4.0% of Direct Digital shares are held by institutional investors. Comparatively, 1.1% of Check-Cap shares are held by institutional investors. 62.8% of Direct Digital shares are held by company insiders. Comparatively, 0.5% of Check-Cap shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Do analysts rate DRCT or CHEK? Direct Digital currently has a consensus price target of $6.00, suggesting a potential upside of 1,238.39%. Given Direct Digital's stronger consensus rating and higher probable upside, analysts clearly believe Direct Digital is more favorable than Check-Cap.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Direct Digital 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Check-Cap 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is DRCT or CHEK more profitable? Check-Cap has a net margin of 0.00% compared to Direct Digital's net margin of -25.99%. Company Net Margins Return on Equity Return on Assets Direct Digital-25.99% N/A -36.29% Check-Cap N/A N/A N/A SummaryDirect Digital beats Check-Cap on 10 of the 14 factors compared between the two stocks. Get Check-Cap News Delivered to You Automatically Sign up to receive the latest news and ratings for CHEK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CHEK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CHEK vs. The Competition Export to ExcelMetricCheck-CapMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.77M$7.05B$5.82B$9.74BDividend YieldN/A1.30%3.84%4.09%P/E Ratio-0.2127.1631.1525.97Price / SalesN/A145.24475.57123.18Price / CashN/A21.6837.1558.38Price / Book0.166.869.116.39Net Income-$17.57M$176.42M$3.26B$265.66M7 Day Performance-3.13%0.58%2.11%1.98%1 Month Performance-16.01%-0.45%5.12%1.33%1 Year Performance-65.36%13.07%31.25%21.15% Check-Cap Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CHEKCheck-Cap0.4077 of 5 stars$0.64+0.8%N/A-67.0%$3.77MN/A-0.2180Short Interest ↑Gap DownDRCTDirect Digital2.5543 of 5 stars$0.40-3.2%$6.00+1,412.5%-87.3%$9.23M$62.29M-0.2260SLGLSol-Gel Technologies1.1098 of 5 stars$16.10+4.3%N/A+330.0%$43.01M$23.93M-13.0950News CoveragePositive NewsEarnings ReportGap DownTrading HaltedBTCYBiotricityN/A$0.60-4.8%N/A+14.8%$14.95M$12.06M-0.5640NXLNexalin Technology3.1369 of 5 stars$0.80+2.6%$5.00+521.4%-25.9%$13.66M$170K-1.063Gap UpTNONTenon Medical1.6213 of 5 stars$1.42+2.2%$5.50+287.3%+198.0%$12.34M$3.28M-0.058Gap DownMHUAMeihua International Medical Technologies0.5178 of 5 stars$0.40+4.1%N/A-39.8%$12.23M$96.90M0.00620News CoverageShort Interest ↑XAIRBeyond Air3.9078 of 5 stars$2.40+3.4%$11.00+358.3%-77.7%$12.12M$3.70M-0.2070News CoverageAnalyst ForecastShort Interest ↑LYRALyra Therapeutics3.237 of 5 stars$7.31+3.7%$100.00+1,268.0%-56.2%$11.59M$1.53M-0.2550DHAIDIH Holding US0.3668 of 5 stars$0.30+26.1%N/A-91.1%$11.33M$64.47M-1.01N/ANegative NewsShort Interest ↑High Trading VolumeOSRHOSRN/A$0.56+5.8%N/AN/A$10.21MN/A0.00N/APositive NewsGap Up Related Companies and Tools Related Companies DRCT Alternatives SLGL Alternatives BTCY Alternatives NXL Alternatives TNON Alternatives MHUA Alternatives XAIR Alternatives LYRA Alternatives DHAI Alternatives OSRH Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CHEK) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Check-Cap Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Check-Cap With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access